These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 34517808)

  • 1. Liver Injury in COVID-19: A Direct Hit or Collateral Damage?
    Vairappan B; Wright G; Corrigal D; Ts R
    Infect Disord Drug Targets; 2022; 22(1):e130921196417. PubMed ID: 34517808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 and the liver: A 2021 update.
    Spearman CW; Aghemo A; Valenti L; Sonderup MW
    Liver Int; 2021 Sep; 41(9):1988-1998. PubMed ID: 34152690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 infection in patients with a normal or abnormal liver.
    Cabibbo G; Rizzo GEM; Stornello C; Craxì A
    J Viral Hepat; 2021 Jan; 28(1):4-11. PubMed ID: 33190321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
    Stratton CW; Tang YW; Lu H
    J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Impact of COVID-19 on Liver Injury.
    Dawood DRM; Salum GM; El-Meguid MA
    Am J Med Sci; 2022 Feb; 363(2):94-103. PubMed ID: 34752738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired coagulation, liver dysfunction and COVID-19: Discovering an intriguing relationship.
    D'Ardes D; Boccatonda A; Cocco G; Fabiani S; Rossi I; Bucci M; Guagnano MT; Schiavone C; Cipollone F
    World J Gastroenterol; 2022 Mar; 28(11):1102-1112. PubMed ID: 35431501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2-induced liver injury: A review article on the high-risk populations, manifestations, mechanisms, pathological changes, management, and outcomes.
    Payus AO; Mohd Noh M; Azizan N; Muthukaruppan Chettiar R
    World J Gastroenterol; 2022 Oct; 28(39):5723-5730. PubMed ID: 36338886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 and liver injury: An ongoing challenge.
    Papagiouvanni I; Kotoulas SC; Pataka A; Spyratos DG; Porpodis K; Boutou AK; Papagiouvannis G; Grigoriou I; Vettas C; Goulis I
    World J Gastroenterol; 2023 Jan; 29(2):257-271. PubMed ID: 36687117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2 Infection and Liver Disease: A Review of Pathogenesis and Outcomes.
    Baldelli L; Marjot T; Barnes E; Barritt AS; Webb GJ; Moon AM
    Gut Liver; 2023 Jan; 17(1):12-23. PubMed ID: 36457261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 and liver disease: mechanistic and clinical perspectives.
    Marjot T; Webb GJ; Barritt AS; Moon AM; Stamataki Z; Wong VW; Barnes E
    Nat Rev Gastroenterol Hepatol; 2021 May; 18(5):348-364. PubMed ID: 33692570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insight into the liver dysfunction in COVID-19 patients: Molecular mechanisms and possible therapeutic strategies.
    Khullar N; Bhatti JS; Singh S; Thukral B; Reddy PH; Bhatti GK
    World J Gastroenterol; 2023 Apr; 29(14):2064-2077. PubMed ID: 37122601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct or Collateral Liver Damage in SARS-CoV-2-Infected Patients.
    Lizardo-Thiebaud MJ; Cervantes-Alvarez E; Limon-de la Rosa N; Tejeda-Dominguez F; Palacios-Jimenez M; Méndez-Guerrero O; Delaye-Martinez M; Rodriguez-Alvarez F; Romero-Morales B; Liu WH; Huang CA; Kershenobich D; Navarro-Alvarez N
    Semin Liver Dis; 2020 Aug; 40(3):321-330. PubMed ID: 32886936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 and liver dysfunction: Epidemiology, association and potential mechanisms.
    Du M; Yang S; Liu M; Liu J
    Clin Res Hepatol Gastroenterol; 2022 Feb; 46(2):101793. PubMed ID: 34428501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The liver injury and gastrointestinal symptoms in patients with Coronavirus Disease 19: A systematic review and meta-analysis.
    Wang H; Qiu P; Liu J; Wang F; Zhao Q
    Clin Res Hepatol Gastroenterol; 2020 Oct; 44(5):653-661. PubMed ID: 32418852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modifications of Medical Care of Chronic Liver Diseases During COVID-19 Pandemic: Necessity or Novelty?
    Soliman HH; Emara MH; Elkadeem M; Abd-Elsalam S
    Infect Disord Drug Targets; 2021; 21(8):e160921189886. PubMed ID: 33397247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19-induced transaminitis and hyperbilirubinemia: Presentation and outcomes.
    Said ZNA; El Habashy SA; Zaky S;
    World J Gastroenterol; 2023 Feb; 29(7):1123-1130. PubMed ID: 36926664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From advanced disease to transplantation: an overview of the liver at the time of COVID-19 pandemic.
    Vitale G; Gitto S; Marra F; Morelli MC
    Intern Emerg Med; 2022 Jan; 17(1):15-24. PubMed ID: 34245423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 and multiorgan failure: A narrative review on potential mechanisms.
    Mokhtari T; Hassani F; Ghaffari N; Ebrahimi B; Yarahmadi A; Hassanzadeh G
    J Mol Histol; 2020 Dec; 51(6):613-628. PubMed ID: 33011887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systems Immunology Analysis Reveals the Contribution of Pulmonary and Extrapulmonary Tissues to the Immunopathogenesis of Severe COVID-19 Patients.
    Hammoudeh SM; Hammoudeh AM; Bhamidimarri PM; Al Safar H; Mahboub B; Künstner A; Busch H; Halwani R; Hamid Q; Rahmani M; Hamoudi R
    Front Immunol; 2021; 12():595150. PubMed ID: 34262555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver diseases in COVID-19: Etiology, treatment and prognosis.
    Wu J; Song S; Cao HC; Li LJ
    World J Gastroenterol; 2020 May; 26(19):2286-2293. PubMed ID: 32476793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.